bioRxivGenomicsPreprint
Pathway-scale variant effect mapping reveals the importance of cell context
Jessica J. SimoniD, Sriram PendyalaiD, A.Felicia AdebanjoiD, Daniel L. HolmesiD, Madeline WalshiD, Allyssa J. VandiiD, Ziyu R. WangiD, Melinda K. WheelockiD, Jordan L. OpsahliD, Aman ShihoraiD, Abbye E. McEweniD, Nahum T. SmithiD, Siobhan O’BrieniD, Melissa HopkinsiD, Alan F. RubiniD, Alice H. BergeriD, Lea M. StaritaiD, Dustin J. MalyiD, Douglas M. FowleriD
- Citations
- 0
Abstract
Variation alters inherent protein properties like thermodynamic stability and catalytic activity, and these intrinsic effects are shaped by the cellular environment. The RAS-MAPK signaling pathway typifies this interplay, with hundreds of proteins acting in concert through regulated states and interactions to transduce signals. To explore how cell context influences variant effects, we measured the abundance and pathway activity of 186,676 variants across 17 MAPK proteins in human cells under diverse conditions, for a total of 503,099 measurements. We discovered 14,412 dominant negative variants, nearly all previously unknown, that disrupt specific domains or interaction interfaces while preserving other functions. MAPK dominant negatives occur at conserved positions and are depleted from the human population relative to other activity-altering variants, representing a distinct constraint on the human genome. Modulating chaperone activity exposed previously hidden effects of genetic variation on protein abundance in human cells, revealing the HSP90 dependence of 67% of missense variants across the pathway. Combining hundreds of experimental and predicted protein interaction structures with variant effect data distinguished functional from non-functional interaction interfaces and revealed how their disruption affected function. We resolved the overlapping KRAS-LZTR1-SOS1 interface into partner-specific and shared binding determinants, identified allosteric networks supporting each interaction, and uncovered distinct mechanisms by which variants promote LZTR1-mediated degradation. Thus, we measure variant effects at pathway scale in human cells, illuminating fundamental MAPK pathway signaling mechanisms and demonstrating that cellular context profoundly shapes the effect of most variants.
- organism: human
- assay: whole-genome sequencing
- research focus: variant effect prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Site saturation mutagenesis of 500 human protein domains reveals the contribution of protein destabilization to genetic disease
Antoni Beltran, Xiang’er Jiang, … Ben Lehner·bioRxiv·Apr 26, 2024
- SPRED1 variants reveal differential impacts on signaling dynamics
Juan Báez-Flores, Alessio Coppola, … Pablo Prieto‐Matos·medRxiv·Jul 9, 2026
- A mutational atlas for Parkin proteostasis
L. Clausen, V. Voutsinos, … R. Hartmann-Petersen·bioRxiv·Jun 8, 2023
- Genetic dissection of MAPK-mediated complex traits across S. cerevisiae
Sebastian Treusch, Frank W Albert, … Leonid Kruglyak·PLoS GeneticsPeer-reviewed·Jan 8, 2015
- memVar: an integrated resource for interpreting human membrane protein variation in molecular and disease contexts
Yizhou Xu, Siming HUANG, … Jianfeng Sun·bioRxiv·Nov 5, 2026
- Missense variants in health and disease affect distinct functional pathways and proteomics features
Anna Laddach, Joseph Chi-Fung Ng, Franca Fraternali·PLoS BiologyPeer-reviewed·Apr 28, 2021